|
Volumn 3, Issue 3, 2005, Pages
|
Direct stenting with sirolimus-eluting stents.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RAPAMYCIN;
CELL PROLIFERATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
HUMAN;
PATHOLOGY;
POSTMARKETING SURVEILLANCE;
RANDOMIZED CONTROLLED TRIAL;
RESTENOSIS;
REVIEW;
STENT;
VASCULAR SMOOTH MUSCLE;
CELL PROLIFERATION;
CORONARY RESTENOSIS;
HUMANS;
MUSCLE, SMOOTH, VASCULAR;
PRODUCT SURVEILLANCE, POSTMARKETING;
RANDOMIZED CONTROLLED TRIALS;
SIROLIMUS;
STENTS;
|
EID: 24644497235
PISSN: 15419215
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1541-9215.2005.04407.x Document Type: Review |
Times cited : (4)
|
References (27)
|